BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Polyphor to Inform about the Financing of its Merger Partner EnBiotix

  Polyphor AG and EnBiotix Inc. announced that EnBiotix has completed a convertible debenture raise of USD 11 million to finance its future operations.

  December 29, 2021

   · 

  2 min read
• Dual Chamber Prefilled Syringes Market to Surpass US$ 3.3 Bn Amidst Advancements in Biologics

  Fact.MR – A Market Research and Competitive Intelligence Provider: Sales of global dual chamber prefilled syringes are projected to reach US$ 3.3 Bn over the forecast period from 2017 to 2026, predicts Fact.MR.

  December 29, 2021

   · 

  7 min read
• Policy

  Amphastar Receives FDA Tentative Approval for Vasopressin

  Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has tentatively approved the Company’s Abbreviated New Drug Application for Vasopressin injection, USP 20 Units/mL, 1mL Single Dose Vial.

  December 29, 2021

   · 

  5 min read
• Business

  Lucira Health and Co-Defend/Co-Protect Announce Expanded Partnership for 2022

  Lucira is the only EUA authorized at-home self-test kit that delivers PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes.

  December 29, 2021

   · 

  7 min read
• Genetown

  Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference

  Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference.

  December 29, 2021

   · 

  2 min read
• Biotech Beach

  Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

  Glaukos Corporation today announced that its management is scheduled to virtually participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 5:15 p.m. ET.

  December 29, 2021

   · 

  1 min read
• Deals

  Philips completes cancellation of 33.5 million shares

  Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 33.5 million of its shares.

  December 29, 2021

   · 

  1 min read
• Following Complete Clearance of Cancer Lesions in Advanced Liver Cancer Patient, Can-Fite is Filing Patent Applications for the Treatment of Various Advanced Solid Tumors

  Following Complete Clearance of Cancer Lesions in Advanced Liver Cancer Patient, Can-Fite is Filing Patent Applications for the Treatment of Various Advanced Solid Tumors.

  December 29, 2021

   · 

  6 min read
• Business

  MindMed Announces Transitions to Management Team

  Bradford Cross , Chief Technology Officer to transition; Don Gehlert , PhD, Chief Scientific Officer to transition to Senior Scientific Advisor.

  December 29, 2021

   · 

  2 min read
• Drug Development

  Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease

  Statera Biopharma, Inc. today announced submission to the U.S. Food and Drug Administration (FDA) of its Phase 3 clinical trial protocol for STAT-201 in the treatment of pediatric Crohn’s Disease (CD).

  December 29, 2021

   · 

  7 min read